olanzapine group:olanzapine

2 trials

Sponsors

Hunan Provincial People's Hospital, Shandong mental health center

Conditions

Olanzapine-induced lipid metabolism disordersmalignant tumor

Phase 2

A randomized controlled clinical trial of Olanzapine or Metoclopramide combined with 5-HT3 receptor antagonist and dexamethasone for the prevention and treatment of nausea and vomiting associated with chemotherapy including Cisplatin

RecruitingChiCTR1800015876

Hunan Provincial People's Hospitalmalignant tumor

Start: 2018-05-01Updated: 2018-04-30

Unknown Phase

Study on the Mechanism of SREBP/PCSK9 Pathway-Mediated Lipid Metabolism Abnormalities Induced by Olanzapine in Schizophrenia and the Therapeutic Effects of PCSK9 Inhibitors

RecruitingChiCTR2500114829

Shandong mental health centerOlanzapine-induced lipid metabolism disorders

Start: 2025-01-01Updated: 2026-01-05